Spanish fashion and beauty group Puig delivered second-quarter results that came in ahead of analyst expectations, but that wasn't enough to make Berenberg more optimistic about the company's longer-term prospects. The German investment bank trimmed its sales and profit forecasts for 2026 through 2028, even as it nudged its price target higher.
Berenberg lifted its price target on Puig to €18.10 and maintained a hold rating. The move reflects a mixed view: the bank acknowledges the recent strength in the business but remains cautious about the years ahead.
What drove the beat
Puig reported 4.1% like-for-like growth in the second quarter, which Berenberg estimated was slightly ahead of the consensus among analysts. The bank attributed the outperformance to strong retail sell-through, a pipeline of new product launches, and the ongoing rollout of Charlotte Tilbury into Boots UK stores.
Charlotte Tilbury, the cosmetics brand Puig acquired a majority stake in a few years ago, has been a key growth driver. Expanding into Boots, one of the UK's largest pharmacy and beauty retailers, gives the brand a much wider physical presence. That move appears to be paying off, according to Berenberg.
However, not all parts of the business were firing on all cylinders. The bank noted that skincare was softer during the quarter, a reminder that even strong performers have pockets of weakness.
Why the cautious outlook
Despite the quarterly beat, Berenberg chose to lower its sales and profit forecasts for the 2026-2028 period. This suggests the bank sees the current strength as potentially temporary or not enough to offset broader challenges.
For everyday investors, this is a useful illustration of how analysts think. A single quarter's results, even if they beat expectations, don't always change the long-term picture. Analysts often adjust their models based on sustained trends rather than one-off surprises. In this case, Berenberg may be factoring in slower growth in certain categories, competitive pressures, or higher costs down the line.
The bank's decision to keep a hold rating—rather than upgrade to buy—reinforces that message. It's essentially saying: the stock is fairly valued at current levels, but there's no strong reason to rush in.
What to watch next
Investors will likely focus on Puig's upcoming capital markets day, scheduled for October 28th. That event could provide more clarity on the company's medium-term strategy, including how it plans to sustain growth in beauty and skincare, and whether it can maintain momentum in key markets.
Berenberg specifically pointed to the Charlotte Tilbury Boots rollout as a positive, so updates on that initiative will be closely watched. Any news about new product launches or expansion into other retail channels could also move the stock.
For those holding Puig shares, the key takeaway is that the company is performing well in the near term, but analysts see some headwinds ahead. The raised price target offers a modest upside from current levels, but the hold rating suggests patience may be warranted.
As always, it's important to remember that analyst ratings are just one opinion. They can be wrong, and they change frequently. Investors should consider their own financial goals and risk tolerance before making any decisions.
Puig's situation is not unique. Many companies beat quarterly estimates only to see analysts trim long-term forecasts. It's a reminder that the market often looks beyond the latest quarter and focuses on sustainable growth.
For more on how analysts adjust their views, check out our coverage of Mashreq Bank's Q2 beat and hold rating and S4 Capital's mixed outlook.
